Fraunhofer-Gesellschaft
Fraunhofer-Gesellschaft

Fraunhofer in Africa and the Middle East

Africa and Middle East

Fraunhofer Senior Advisor help the Fraunhofer Institutes and their partners to set up business connections and collaborations in Africa and the Middle East. The Fraunhofer-Gesellschaft is actively involved in contract research, scientific collaborations and capacity building in this dynamic region.

This local Fraunhofer presence benefits commercial enterprises in their business activities as well as government customers in implementing economic, research and development policies.

Currently most of the Fraunhofer activities in these regions are focused on Egypt, Israel and South Africa. In addition other countries in North Africa and Sub-Saharan Africa are of growing interest and some initial cooperations are under way.

South Africa

Fraunhofer Senior Advisor South Africa

 

Dr. Oliver Damm

proConsult, 5 De Havilland Crescent, Persequor Technopark 0020, P O Box 58
Pretoria , South Africa
Phone +27 82 413-5715

Israel

Fraunhofer Senior Advisor Israel

 

Prof. Dr.-Ing. Rafael Wertheim

Lavon Industrial Park 20118 Lavon, Israel
Phone + 972 544 660 658

Fraunhofer Project Center for Cybersecurity at Hebrew University of Jerusalem FPC_CS@HUJI

The Fraunhofer Project Center for Cybersecurity at Hebrew University of Jerusalem FPC_CS@HUJI conducts applied research on the security of networks and critical infrastructures. Both partners, the Hebrew University's acclaimed School of Computer Science and Engineering and the Fraunhofer Institute for Secure Information Technology SIT are coordinating their complementary competences to deliver vital results for the rapidly growing cybersecurity market as well as focus on agenda setting.

Fraunhofer Project Center for Drug Discovery and Delivery at the Hebrew University of Jerusalem

The central idea of the Fraunhofer Project Center for Drug Discovery and Delivery @ Hebrew University of Jerusalem, Israel is to exploit mechanisms of innate immunity in combination with targeted drug delivery. Immunemodulatory compounds are to be developed in a way that both viral infections and inflammatory diseases can be addressed more effectively. Targeted delivery of these compounds is to be achieved via liposomal nanoparticles to ensure high accumulation at the disease site. The Center is a cooperation between the Fraunhofer Institute for Interfacial Engineering and Biotechnology and the Institute for Drug Research at the Hebrew University.

Related Links: